The Drug Enforcement Administration’s move to shut down its OxyContin program will likely cause a wave of withdrawal calls for other opioids, like fentanyl and methadone.
It also could drive up prescription costs for many people.
That’s according to Dr. David G. Kahl, a New York University professor and expert on the opioid crisis.
He says that as the federal government’s efforts to cut the number of prescriptions for opioid painkillers have been rolled back, patients who used to get prescriptions for those drugs are going to have to start buying more of those pills.
“It’s going to affect all of us, because the demand for opioids is going to be higher than the supply of those drugs,” Kahl said.
“I think it’s going be a real impact on the healthcare system.”
In addition to the opioid prescription crisis, Kahl says that the Trump administration has made it harder for the opioid manufacturers to meet demand for the drugs.
The U.S. is now the second-largest producer of OxyContin and other opioids in the world.
The drugs have become popular in recent years because they can be prescribed with a low-cost, low-abuse prescription, which makes them easier to obtain and cheaper than their predecessors.
The problem with OxyContin, which comes in tablets or capsules, is that it can be laced with fentanyl, an illegal narcotic.
When mixed with other opioids such as codeine or oxycodone, the pills can become very potent and addictive.
It can be extremely dangerous to take the pills for extended periods of time, making it the main reason many people have stopped taking them altogether.
Some opioid-dependent patients have even reported experiencing withdrawal symptoms from the drugs, like headaches and nausea.
In the first half of 2018, the federal Centers for Disease Control and Prevention reported that more than 50,000 people in the U.K. were prescribed OxyContin.
And the U-Haul shipment to Mexico sent nearly 500 people to the country in just a week.
That is a significant increase from the roughly 4,000 to 5,000 patients who were prescribed the drugs in the first six months of the year.
That surge in opioid use in the United States could have a devastating effect on the health system.
According to Kahl’s research, the supply for opioids was limited at the beginning of the epidemic, but that may not be the case for many other countries.
In Europe, for example, the European Union is in the midst of a crackdown on opioids, with new laws designed to keep out drug traffickers and the sale of controlled substances.
In many countries, prescription painkillers are sold without a prescription.
In Germany, for instance, prescription drugs that were previously available only to doctors for a few hours a week are now freely available for patients to buy for free.
In other countries, the number and potency of opioids have been increasing at a rate that can’t be explained by demand.
For instance, in Brazil, the opioid problem is so bad that the government recently banned sales of oxycodones and hydrocodone for people who have used them for more than six months.
That led to a surge in deaths from prescription opioids in Brazil.
The United Kingdom is currently the only major economy in the European region to have a prescription-drug overdose crisis, with the number reporting over 3,000 deaths per year, according to the UBS Global Healthcare Institute.
It is estimated that about a third of those deaths are attributed to prescription painkiller abuse.
That may be one reason why, in Europe, the overdose crisis is getting a lot of attention from policymakers and experts.
Some experts say that the opioid epidemic in the West may be the most serious one on record in the developed world.
“If we are not going to address the issue of prescription opioid abuse in Europe in the near future, then the economic damage will be very, very severe,” Kallenberg said.
But Kahl disagrees.
“We have been living in a very dangerous era,” he said.